530 related articles for article (PubMed ID: 11493009)
1. Crystal structure of PTP-SL/PTPBR7 catalytic domain: implications for MAP kinase regulation.
Szedlacsek SE; Aricescu AR; Fulga TA; Renault L; Scheidig AJ
J Mol Biol; 2001 Aug; 311(3):557-68. PubMed ID: 11493009
[TBL] [Abstract][Full Text] [Related]
2. Structure of the hematopoietic tyrosine phosphatase (HePTP) catalytic domain: structure of a KIM phosphatase with phosphate bound at the active site.
Mustelin T; Tautz L; Page R
J Mol Biol; 2005 Nov; 354(1):150-63. PubMed ID: 16226275
[TBL] [Abstract][Full Text] [Related]
3. PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif.
Pulido R; Zúñiga A; Ullrich A
EMBO J; 1998 Dec; 17(24):7337-50. PubMed ID: 9857190
[TBL] [Abstract][Full Text] [Related]
4. Two clusters of residues at the docking groove of mitogen-activated protein kinases differentially mediate their functional interaction with the tyrosine phosphatases PTP-SL and STEP.
Tárrega C; Blanco-Aparicio C; Muñoz JJ; Pulido R
J Biol Chem; 2002 Jan; 277(4):2629-36. PubMed ID: 11711538
[TBL] [Abstract][Full Text] [Related]
5. The MAP-kinase ERK2 is a specific substrate of the protein tyrosine phosphatase HePTP.
Pettiford SM; Herbst R
Oncogene; 2000 Feb; 19(7):858-69. PubMed ID: 10702794
[TBL] [Abstract][Full Text] [Related]
6. A novel regulatory mechanism of MAP kinases activation and nuclear translocation mediated by PKA and the PTP-SL tyrosine phosphatase.
Blanco-Aparicio C; Torres J; Pulido R
J Cell Biol; 1999 Dec; 147(6):1129-36. PubMed ID: 10601328
[TBL] [Abstract][Full Text] [Related]
7. Differential interaction of the tyrosine phosphatases PTP-SL, STEP and HePTP with the mitogen-activated protein kinases ERK1/2 and p38alpha is determined by a kinase specificity sequence and influenced by reducing agents.
Muñoz JJ; Tárrega C; Blanco-Aparicio C; Pulido R
Biochem J; 2003 May; 372(Pt 1):193-201. PubMed ID: 12583813
[TBL] [Abstract][Full Text] [Related]
8. Interaction of mitogen-activated protein kinases with the kinase interaction motif of the tyrosine phosphatase PTP-SL provides substrate specificity and retains ERK2 in the cytoplasm.
Zúñiga A; Torres J; Ubeda J; Pulido R
J Biol Chem; 1999 Jul; 274(31):21900-7. PubMed ID: 10419510
[TBL] [Abstract][Full Text] [Related]
9. Docking interactions induce exposure of activation loop in the MAP kinase ERK2.
Zhou T; Sun L; Humphreys J; Goldsmith EJ
Structure; 2006 Jun; 14(6):1011-9. PubMed ID: 16765894
[TBL] [Abstract][Full Text] [Related]
10. Restoration of potent protein-tyrosine phosphatase activity into the membrane-distal domain of receptor protein-tyrosine phosphatase alpha.
Buist A; Zhang YL; Keng YF; Wu L; Zhang ZY; den Hertog J
Biochemistry; 1999 Jan; 38(3):914-22. PubMed ID: 9893986
[TBL] [Abstract][Full Text] [Related]
11. Structure, dynamics and binding characteristics of the second PDZ domain of PTP-BL.
Walma T; Spronk CA; Tessari M; Aelen J; Schepens J; Hendriks W; Vuister GW
J Mol Biol; 2002 Mar; 316(5):1101-10. PubMed ID: 11884147
[TBL] [Abstract][Full Text] [Related]
12. Crosstalk between cAMP-dependent kinase and MAP kinase through a protein tyrosine phosphatase.
Saxena M; Williams S; Taskén K; Mustelin T
Nat Cell Biol; 1999 Sep; 1(5):305-11. PubMed ID: 10559944
[TBL] [Abstract][Full Text] [Related]
13. New insights into the catalytic activation of the MAPK phosphatase PAC-1 induced by its substrate MAPK ERK2 binding.
Zhang Q; Muller M; Chen CH; Zeng L; Farooq A; Zhou MM
J Mol Biol; 2005 Dec; 354(4):777-88. PubMed ID: 16288922
[TBL] [Abstract][Full Text] [Related]
14. Structural and functional effects of disease-causing amino acid substitutions affecting residues Ala72 and Glu76 of the protein tyrosine phosphatase SHP-2.
Bocchinfuso G; Stella L; Martinelli S; Flex E; Carta C; Pantaleoni F; Pispisa B; Venanzi M; Tartaglia M; Palleschi A
Proteins; 2007 Mar; 66(4):963-74. PubMed ID: 17177198
[TBL] [Abstract][Full Text] [Related]
15. Reversible oxidation of the membrane distal domain of receptor PTPalpha is mediated by a cyclic sulfenamide.
Yang J; Groen A; Lemeer S; Jans A; Slijper M; Roe SM; den Hertog J; Barford D
Biochemistry; 2007 Jan; 46(3):709-19. PubMed ID: 17223692
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of mitogen-activated protein kinases by a mammalian tyrosine-specific phosphatase, PTPBR7.
Ogata M; Oh-hora M; Kosugi A; Hamaoka T
Biochem Biophys Res Commun; 1999 Mar; 256(1):52-6. PubMed ID: 10066421
[TBL] [Abstract][Full Text] [Related]
17. Proteolytic processing of the receptor-type protein tyrosine phosphatase PTPBR7.
Dilaver G; van de Vorstenbosch R; Tárrega C; Ríos P; Pulido R; van Aerde K; Fransen J; Hendriks W
FEBS J; 2007 Jan; 274(1):96-108. PubMed ID: 17147696
[TBL] [Abstract][Full Text] [Related]
18. The crystal structure of JNK2 reveals conformational flexibility in the MAP kinase insert and indicates its involvement in the regulation of catalytic activity.
Shaw D; Wang SM; Villaseñor AG; Tsing S; Walter D; Browner MF; Barnett J; Kuglstatter A
J Mol Biol; 2008 Nov; 383(4):885-93. PubMed ID: 18801372
[TBL] [Abstract][Full Text] [Related]
19. Colocalisation of the protein tyrosine phosphatases PTP-SL and PTPBR7 with beta4-adaptin in neuronal cells.
Dilaver G; Schepens J; van den Maagdenberg A; Wijers M; Pepers B; Fransen J; Hendriks W
Histochem Cell Biol; 2003 Jan; 119(1):1-13. PubMed ID: 12548400
[TBL] [Abstract][Full Text] [Related]
20. Protein tyrosine phosphatase epsilon inhibits signaling by mitogen-activated protein kinases.
Toledano-Katchalski H; Kraut J; Sines T; Granot-Attas S; Shohat G; Gil-Henn H; Yung Y; Elson A
Mol Cancer Res; 2003 May; 1(7):541-50. PubMed ID: 12754301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
